Browse By: Country ι Category ι Publisher ι Tag

Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition

Pages » 208
Published By » JustPharmaReports.com
Price » $2350
In stock
View Report Details
Description

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. But is this enough to assure premium prices and special status in an era of budget limitations, and growing demands for evidence of clinical and cost effectiveness? Payers are becoming increasingly strict. Four of the first seven orphan drugs to enter Germany’s AMNOG procedure were considered to bring only minor additional benefit and for two others the benefit was deemed non-quantifiable.... Click here for more details


Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2011 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only h
Published Date: Jun 2011
Price: $2300
Market Access Korea: Breaking into the Developed World\'s Fastest Growing Pharmaceutical Market
South Korea as a country has been an economic success story and the origin of much cutting edge technology, but its pharmaceutical market can now also be given ‘Asian tiger’ status. The past four years have seen total sales growth of 15.6%, 13.5%, 12.4% and 13.8% respectively. IMS
Published Date: Nov 2010
Price: $1380
Orphan Drugs in Asia-Pacific: From Designation to Pricing, Funding & Market Access
A major new report Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access focuses on five developed markets in the region: Japan, South Korea, Taiwan, Singapore and Australia. Each has passed specific measures to promote the development, registration and/or commer
Published Date: Feb 2010
Price: $2320
Biosimilars: Current Situation & Future Prospects, Worldwide
The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry. On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in the global biologics market expected to lose some degree of protection by 2019. All major countr
Published Date: Mar 2012
Price: $3000
Pharmaceutical Pricing & Distribution in Japan, 2010 Update
The author’s 2008 major title ‘Pharmaceutical Pricing & Distribution in Japan’ was described by PhRMA Japan as ‘a superb report…to understand Japan there is nothing better’. His new report packs all the essentials needed to optimise market access and life
Published Date: Oct 2011
Price: $760
Pharmaceutical Pricing & Distribution in Japan, 2012 Update
No serious pharmaceutical company can afford to ignore Japan, a $120 billion market, the second-largest in the world. It remains a tough and highly competitive market to crack, however, with the environment for developing and marketing medicines dominated by price.  No new bran
Published Date: Jun 2012
Price: $1400
Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
Managed entry agreements apply to an increasing number of new, innovative drugs in a growing number of markets. They are designed to share the risk between the manufacturer and the payer, consequent on uncertainties - usually at launch - about the product’s value (clinical- and cost-effect
Published Date: Feb 2013
Price: $1050
Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2013 Edition
The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing clinical need, a strong patient voice and the treatments themselves sometimes offer the only hope. B
Published Date: Oct 2013
Price: $2350

 


 

Related News

Brent Crude Oil Prices Rise Above $97 after China: reports PMI
Brent crude experienced a rise of $97 per barrel on Tuesday. This was after a factory in China unexpectedly soared in terms of demand outlook in the global market in September.  The expectations proposed by the analysts for a reading of 50 about Brunt crude oil were beat from 50.2 in August to 50.5 in September as orders continued to rise, reported the HSBC China Purchasing Managers’ Index (PMI).  For November, Brent was up 15 cents by 0646 GMT reaching a value $97.12 per b
Date: Sep 25

Gentag, Welch Allyn Partner in Wireless Medical Device Deal
An agreement between Gentag, Inc. and Welch Allyn was announced on Tuesday that deals with a strategic plan to further the wireless medical devices sector. Gentag deals in wireless solutions for diagnostics, personal healthcare and machine-to-machine applications. Welch Allyn, on the other hand, is a major diagnostic medical device firm that specializes in pragmatic innovations. Both the companies have decided to partner up in order to provide near-field communication (NFC) technology for medica
Date: Oct 29

New Online Database Scores Your Grocery Rankings for Nutritional Value
A brand new online database named Food Scores is a proposed plan by the Environmental Working Group. This organization is intended to help consumers access sustainably produced food products locally available at stores, farms, farmers market, restaurants, and other CSA (community supported agriculture) spanned throughout the United States.  Food Scores are based on three major considerations chiefly given to three different factors: ingredient concerns, nutrition, and degree of processin
Date: Oct 29

General Motors to Build More Parts of Chevrolet Volt in Michigan
General Motors Co. is planning to shift the production of its 2016 Chevrolet Volt project from Mexico to Michigan. An official announcement about the same is expected to be delivered by the GM’s Chief Executive Mary Barra at the Detroit Economic Club. GM’s redesigned, gasoline-electric technology fused hybrid 2016 Volt is slated to go on sale by the second half of 2015. The unit of engine production of this project is also set to be shifted to Michigan, hints the company. The n
Date: Oct 29

Genetic Factors Play a Major Role in an Individuals Response to Statins
Clinical trials and analysis on almost 40000 individuals pertaining to statin treatment has led to the identification of two novel genetic variants which have an impact on the response of ‘bad’ cholesterol to statin therapy. Statins are mostly prescribed to those people who suffer from high levels of ‘bad’ cholesterol in their bodies. Statins bring down the levels of the ‘bad’ cholesterol by almost 55% and are also effective in reducing the chances of developi
Date: Oct 29

BASF Increase tBA Plant Capacity by 60% in China
BASF has announced its plans to increase its production of tertiary Butylamine (tBA) by 60% at its facility in Nanjing Chemical Industry Park, China. The 60% increase will mean its production will shoot up from 10,000 tons to 16,000 tons per year. According to Guido Voit, the Senior Vice-President the expansion will help the company meet the growing demand in the Asia Pacific region in the coming years. The demand projection indicates that China will consume the largest market share. This mov
Date: Oct 29

China to Import Sorghum from Argentina
According to latest reports, sometime soon this year, China will open its markets to sorghum from Argentina. This step will create competition for the US market which until now was a significant exporter of sorghum to China. The demand for sorghum from China is mainly driven by the market for distilled alcohol. Animal feed producers in China have turned to sorghum as an inexpensive alternative, since corn is highly priced in China. Furthermore, demand for sorghum in China is also driven by gr
Date: Oct 28

Global Car Rental Market Research Reports and Industry Analysis
The global car rental market [http://www.marketresearchreports.biz/analysis/220733] is composed of companies that offer an automobile on lease to consumers who may not own or have access to their own vehicles. Such companies rent out vehicles to customers for a stipulated duration, which could range from a few hours to a few days to a few months. Depending on the type of car rented and the duration it is rented for, the car rental company will charge a fee from its customers. Often, these compan
Date: Oct 28

Global and China FPCB (Flexible Printed Circuit Board) Industry Analysis and Market Research Reports
Flexible printed circuit boards (FPCB) are used in applications where rigid PCBs are not capable of being fitted. According to market research reports, the global FPCB market is projected to touch US$12.686 billion in 2015, charting a CAGR of 9.4% from its 2013 value of US$11.321 billion. A few contemporary applications where FPCB is used include: displays such as touch screens and LCD panels, computing applications such as ODD and HDD, and communications applications such as mobile phones. A
Date: Oct 28

Global Medical Publishing Market Research Reports and Industry Analysis
The medical publishing industry [http://www.marketresearchreports.biz/analysis/182505] can be credited for bringing cutting-edge research and data to the fingertips of the scientific community. There are a number of medical publishing companies that specialize in peer reviews, medical journals, and other publications that carry the very latest developments and initiatives in the medical sector.  Important as this industry may be, market analysts predict a marginal decline in the medical
Date: Oct 28

Upcoming Reports

Acute Myeloid Leukemia (AML) Therapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
Acute myeloid leukemia grows at a fast pace and is found in the blood and bone marrow. The leukemia therapeutics market is divided into four segments namely acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myeloid leukemia. In the disease process, imma
Published By: Transparency Market Research
Price: $4795
Antibiotic Market - Global Industry Size, Share, Trends, Analysis And Forecast, 2012 - 2018
An antibiotic is a compound or a substance that fights bacterial infections and kills or slow down their growth. The antibiotic market is witnessing high growth due new product innovations and higher investment in R & D activity. Moreover, the other regulatory concerns to control the antibioti
Published By: Transparency Market Research
Price: $4795
Next Generation Sequencers Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Next generation sequencers are used inthe sequencing technologies which massively parallelize the DNA sequencing process rather than being limited to single or few fragments of DNA. The next generation sequencing (NGS) technology enables rapid sequencing and produce thousands and millions of seque
Published By: Transparency Market Research
Price: $4795
Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency Market Research
Price: $4795
Prenatal Diagnostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Prenatal diagnostics is a procedure for testing of diseases before the birth of a child, to determine certain inheritable disorders such as chromosome abnormalities, Down’s syndrome, genetic diseases, neural tube defects, and other conditions. It can be conducted by various procedures of scr
Published By: Transparency Market Research
Price: $4795
Pediatric Vaccines Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The global pediatric vaccine market is forecasted to reach $24.3 billion by the year 2017 at a compounded annual growth rate of 11.5 % during 2011-2017. This growth in revenues is expected to be driven by the introduction of new molecules that are currently in regulatory filing stage and those i
Published By: Transparency Market Research
Price: $4795
Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging therapies. Acne is the largest market segment of the dermatolog
Published By: Transparency Market Research
Price: $4795
Hepatitis C Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The world market for HCV drugs represents an area of potential opportunities in developed as well as developing countries. Because of the technological advancements and effectiveness, many big market players are focusing on development of innovative drugs for HCV. Major companies are forming coali
Published By: Transparency Market Research
Price: $4795
EPharmacies Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
The global market for ePharmacies is projected to reach USD 51.75 billion by the end of 2017 owing to the increasing number of tech-savvy people and rising demand for prescription drugs. The ePharmacies meeting the regulatory standards set by the government and following ethical business practices
Published By: Transparency Market Research
Price: $4795
Congestive Heart Failure Treatment Devices Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018
The global market for congestive heart failure treatment devices is expected to reach $5.9 billion by the year 2016 at the compounded annual growth rate of 11.7% during the forecasted period. This growth is mainly attributed by the rising incidences of heart failures across the world. American mar
Published By: Transparency Market Research
Price: $4795